InflaRx (IFRX) Total Liabilities (2022 - 2025)

InflaRx (IFRX) has disclosed Total Liabilities for 4 consecutive years, with $15.9 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 1.9% to $15.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.9 million through Dec 2025, up 1.9% year-over-year, with the annual reading at $15.9 million for FY2025, 1.9% up from the prior year.
  • Total Liabilities hit $15.9 million in Q4 2025 for InflaRx, up from $15.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $19.0 million in Q4 2023 to a low of $14.3 million in Q4 2022.
  • Historically, Total Liabilities has averaged $16.2 million across 4 years, with a median of $15.8 million in 2024.
  • Biggest five-year swings in Total Liabilities: soared 32.3% in 2023 and later decreased 17.72% in 2024.
  • Year by year, Total Liabilities stood at $14.3 million in 2022, then skyrocketed by 32.3% to $19.0 million in 2023, then dropped by 17.72% to $15.6 million in 2024, then rose by 1.9% to $15.9 million in 2025.
  • Business Quant data shows Total Liabilities for IFRX at $15.9 million in Q4 2025, $15.6 million in Q4 2024, and $19.0 million in Q4 2023.